GlassScriptPhysician profile
Stephen Edward Dunham
NPI 1508387655
$3,032.32
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $189 · 2021: $1,700 · 2022: $355 · 2023: $161 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,276.37 | 2021 | |
| Stryker Corporation | $466.51 | 2019-2024 | Easyfuse, Variax, Dart-Fire |
| Smith+Nephew, INC. | $303.06 | 2020-2023 | Grafix Pl |
| Organogenesis INC. | $194.53 | 2019-2023 | Puraply |
| Abbvie INC. | $172.77 | 2021-2024 | Dalvance |
| Treace Medical Concepts, INC. | $145.91 | 2023-2024 | |
| Horizon Therapeutics Plc | $125.00 | 2019 | |
| Pacira Therapeutics, INC. | $124.98 | 2020 | |
| Ossio INC | $98.64 | 2019 | |
| Heron Therapeutics, INC. | $39.05 | 2021 | |
| Advanced Oxygen Therapy INC. | $28.67 | 2021 | |
| Aroa Biosurgery Incorporated | $20.13 | 2023 | |
| Paratek Pharmaceuticals, INC. | $18.66 | 2021 | |
| Kerecis Limited | $18.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.